The Russian-made Sputnik V coronavirus vaccine has shown the best result in preventing death from Covid-19, compared to other flagship formulas, according to an in-depth study based on Hungary’s mass vaccination campaign.
The comparative analysis of the performance of the different jabs used in this central European country was unveiled on Thursday by the Russian Direct Investment Fund (RDIF), the sovereign fund that financed the development of the jab.
“With 98% effectiveness in preventing COVID-related mortality and 85.7% effectiveness against coronavirus infection, Sputnik V has demonstrated the best results among five vaccines (Sputnik V, Moderna, Pfizer-BioNTech , Sinopharm and AstraZeneca) administered in EU Member State Hungary as part of an independent study based on data from 3.7 million people ”, RDIF CEO Kirill Dmitriev said in a statement Thursday.
While beating all of its competitors in terms of protection against coronavirus-related mortality, Sputnik V came second in Hungary in preventing the disease itself. The best result, in this category, was delivered by the Moderna shot made in the USA, which demonstrated an efficiency of 98% against 86% shown by Sputnik V.
The Russian-made shot also turned out to be “100% effective against COVID-related deaths in people aged 16 to 44” according to the findings.
The new study comes a day after RDIF presented to the general public an analysis of the long-term results of a mass vaccination campaign in San Marino, which primarily used Sputnik V. Some 70% of the 34,000 residents of the country. European micro-state received the Russian-made jab.
The vaccine has shown extremely high efficacy in San Marino, with “Only 0.75 per 1,000 peopleWho were vaccinated and ended up being hospitalized. Jab also maintained high efficacy over long periods of time, remaining about 80% effective against disease six to eight months after the second dose was given.
The long-term effectiveness of Sputnik V “Is much higher than the officially published efficacy of mRNA vaccines”, noted the RDIF.
Do you think your friends would be interested? Share this story!